US 8921376
Pyrrolopyridines useful as inhibitors of protein kinase
granted A61PA61P1/04A61P1/16
Quick answer
US patent 8921376 (Pyrrolopyridines useful as inhibitors of protein kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P1/04, A61P1/16, A61P11/00, A61P11/06